Victory Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-15,593
Closed -$530K 2867
2021
Q3
$530K Buy
15,593
+153
+1% +$4.88K ﹤0.01% 2144
2021
Q2
$565K Sell
15,440
-616
-4% -$23.9K ﹤0.01% 2142
2021
Q1
$720K Sell
16,056
-1,101
-6% -$51.3K ﹤0.01% 2047
2020
Q4
$979K Sell
17,157
-13,958
-45% -$827K ﹤0.01% 1793
2020
Q3
$1.6M Sell
31,115
-13,779
-31% -$675K ﹤0.01% 1516
2020
Q2
$2.68M Sell
44,894
-45,286
-50% -$2.42M ﹤0.01% 1342
2020
Q1
$3.71M Buy
90,180
+48,781
+118% +$2.71M ﹤0.01% 1363
2019
Q4
$2.58M Buy
41,399
+6,228
+18% +$296K ﹤0.01% 1401
2019
Q3
$1.19M Buy
35,171
+34,463
+4,868% +$1.02M ﹤0.01% 1654
2019
Q2
$16K Hold
708
﹤0.01% 1799
2019
Q1
$16K Hold
708
﹤0.01% 1752
2018
Q4
$15K Sell
708
-135
-16% -$3.32K ﹤0.01% 1749
2018
Q3
$33K Buy
843
+111
+15% +$4.1K ﹤0.01% 1740
2018
Q2
$29K Buy
+732
New +$21.5K ﹤0.01% 1781
2017
Q4
Sell
-60,000
Closed -$1.14M 1843
2017
Q3
$1.14M Buy
+60,000
New +$1.1M ﹤0.01% 1189

Other funds holding DCPH

Victory Capital Management's DCPH Position: Q4 2021 in Review

Victory Capital Management sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q4 2021, closing a stake of 15,593 shares — an estimated $530K sold.

Victory Capital Management first reported a position in DCPH in Q3 2017 and held it in 15 quarters. The position peaked at $3.71M in Q1 2020. 140 funds tracked by Wall St. Rank hold DCPH as of Q4 2021.

  • Victory Capital Management reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Victory Capital Management sold 15,593 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q4 2021, an estimated $530K.
  • Victory Capital Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 15 quarters.
  • Victory Capital Management's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $3.71M in Q1 2020.
  • 140 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q4 2021.

Based on Victory Capital Management's 13F filing for Q4 2021, filed 7 Feb 2022.